Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles

被引:14
|
作者
Liu, Juan [1 ,2 ]
Hu, Xixue [3 ,4 ]
Jin, Shubin [5 ]
Liang, Xing-Jie [3 ,4 ]
Ma, Xiaowei [1 ]
机构
[1] China Agr Univ, Coll Vet Med, Natl Ctr Vet Drug Safety Evaluat, Beijing 100193, Peoples R China
[2] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Hepatopancreatobiliary Ctr, Translat Res Ctr, Beijing, Peoples R China
[3] Chinese Acad Sci, CAS Ctr Excellence Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China
[4] Natl Ctr Nanosci & Technol China, Beijing 100190, Peoples R China
[5] Beijing Municipal Inst Labour Protect, 55 Taoranting Rd, Beijing 100054, Peoples R China
基金
北京市自然科学基金;
关键词
POLYMERIC MICELLES; NANOPARTICLES; DELIVERY; ANTICANCER; TRANSFERRIN; DOXORUBICIN; PARTICLES; THERAPY; SYSTEM; GLIOMA;
D O I
10.1039/d1tb02540f
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Rapid release and clearance of antitumor drugs in vivo are the main factors used to evade the effectiveness of chemotherapeutics. Targeted delivery and controlled release of drugs are the most pressing dilemmas in cancer therapy. Herein we report the design and fabrication of multifunctional mesoporous silica nanoparticles coated with poly(N-isopropylacrylamide)-co-acrylic acid and calcium phosphate (MSCNs) with pH-triggered chemotherapeutic release and dual-targeting functions. By decorating the nanoparticle surface with a transferrin (Tf)/RGD ligand, these nanoparticles are capable of not only recognizing the intrinsic pH difference between tumor and normal tissues, but also targeting the lesion location. It was shown that Tf/RGD-MSCNs delivered the anti-tumor drug doxorubicin more efficiently into lysosomes and the resulting DOX-loaded nanoparticles (DOX-Tf/RGD-MSCNs) showed a stronger inhibitory effect towards tumor cell growth than free DOX and DOX delivered by unmodified MSNs. Moreover, the nanoparticles are more biocompatible than uncoated mesoporous silica nanoparticles. All these results indicate that Tf/RGD-MSCNs have great potential as a novel drug carrier in therapeutic applications against cancers.
引用
收藏
页码:384 / 395
页数:12
相关论文
共 5 条
  • [1] Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity
    Singh, Rajendra K.
    Patel, Kapil D.
    Mahapatra, Chinmaya
    Parthiban, S. Prakash
    Kim, Tae-Hyun
    Kim, Hae-Won
    ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (01) : 288 - 299
  • [2] Dual passively active tumor-targeting micelles for pH-triggered intracellular anticancer drug release
    Yuan, Jianchao
    Xu, Weibing
    Chen, Jingjing
    Zhao, Jie
    Mu, Yanqiong
    Wu, Yanpeng
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2014, 29 (05) : 415 - 431
  • [3] Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer
    Li, Wei-Ming
    Chiang, Chih-Sheng
    Huang, Wei-Chen
    Su, Chia-Wei
    Chiang, Min-Yu
    Chen, Jian-Yi
    Chen, San-Yuan
    JOURNAL OF CONTROLLED RELEASE, 2015, 220 : 107 - 118
  • [4] Tumor targeting pH-triggered fluorescence-switchable hyaluronic acid-based micelles with aggregation-induced emission activity for tracing drug release and intelligent drug delivery
    Liang, Na
    Zhao, Wei
    Li, Siyi
    Li, Xiaoxin
    Liu, Zhenrong
    Jiang, Kun
    Sun, Shaoping
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 277
  • [5] Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane
    Liang, Bin
    Jiang, Dawei
    Pan, Luqi
    Xiong, Fang
    Feng, Shuya
    Wu, Shenghao
    Ye, Haige
    Yu, Zhijie
    Shi, Changcan
    Gao, Shenmeng
    ACTA BIOMATERIALIA, 2022, 145 : 246 - 259